FLAREX
LOE Approachingfluorometholone acetate
NDAOPHTHALMICSUSPENSION/DROPS
Approved
Feb 1986
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
FLAREX (fluorometholone acetate) is clinical pharmacology corticosteroids suppress the inflammatory response to inciting agents of mechanical, chemical or immunological nature. First approved in 1986.
Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FLAREX (fluorometholone acetate) is a topical ophthalmic corticosteroid suspension approved in 1986 for treating inflammatory eye conditions. It suppresses inflammatory response to mechanical, chemical, or immunological insult and is applied directly to the eye as drops. The drug works by modulating the inflammatory cascade, though the exact mechanism remains incompletely understood.
$4MPart D
LOE ApproachingProduct approaching loss of exclusivity with modest Medicare spending signals a mature, declining franchise requiring defensive commercial strategies.
Mechanism of Action
CLINICAL PHARMACOLOGY Corticosteroids suppress the inflammatory response to inciting agents of mechanical, chemical or immunological nature. No generally accepted explanation of this steroid property has been advanced. Corticosteroids cause a rise in intraocular pressure (IOP) in susceptible…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
FLAREX generates minimal active job creation in pharma due to its mature lifecycle and low commercial velocity ($4M Part D spending). Roles available are typically maintenance-focused in regulatory, medical information, and field compliance rather than strategic commercial or medical affairs positions.
External Resources
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.